Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Ristić, Miljko (57214043577)"

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Heart transplantation in a patient with left ventricular assist device after pump thrombosis –The first case report in Serbia
    (2020)
    Terzić, Duško (57195538891)
    ;
    Putnik, Svetozar (16550571800)
    ;
    Nestorović, Emilija (56090978800)
    ;
    Bilbija, Ilija (57113576000)
    ;
    Bukarica, Ljiljana Gojković (12041549400)
    ;
    Jovičić, Vladimir (55354036700)
    ;
    Rajković, Jovana (57194111917)
    ;
    Ristić, Miljko (57214043577)
    Introduction. The device thrombosis is one of the most serious complications of the left ventricle assist device implantation with a high mortality and morbidity rate. Case report. A 59-year-old male was implanted by left ventricular assist device Heart Mate II as a bridge to transplantation seventeen months before the onset of a potentially fatal complication – the thrombosis with the complete obstruction of the device. Despite the aggressive pharmacological treatment following the initial suspicion of the pump thrombosis, the patient condition got worse with the final “pump off” alarm that marked the discontinuance of the pump work as a result of the complete obstruction by the thrombus. An appropriate occurrence of an adequate donor resulted in a successful surgical treatment – the heart transplantation. Conclusion. The urgent heart transplantation by the first priority rank, or the device replacement, although technically extremely demanding procedures, are successful treatment options for these patients. © 2020 Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Preoperative echocardiographic parameters influencing quality of life five years after coronary artery bypass graft surgery
    (2009)
    Zdravković, Marija (24924016800)
    ;
    Ristić, Miljko (57214043577)
    ;
    Milić, Nataša (7003460927)
    ;
    Zdravković, Darko (23501022600)
    ;
    Krotin, Mirjana (25632332600)
    ;
    Randjelović, Tomislav (6602693978)
    Background/Aim. Factors associated with mortality and morbidity following coronary artery bypass graft surgery have been well defined and the Parsonnet score is widely used in mortality prediction. The evaluation of quality of life has not been still implemented in everyday work and preoperative echocardiographic factors affecting the quality of life in patients undergoing coronary artery bypass graft surgery have been poorly documented. The aim of this study was to evaluate echocardiographic parameters influencing quality of life following coronary artery bypass graft surgery and its correlation with widely used Parsonnet score. Methods. A total of 449 consecutive patients with myocardial revascularization, operated during 1999 and 2000 were enrolled in this retrospective-prospective study. The patients with comorbidities were excluded as well as those with in complete myocardial revascularization. A group of 180 patients who accepted to participate in quality of life evaluation was followed for 60 months. The quality of life was evaluated using a questionnaire SF-36. Results. The mean patients' age was 57.8 ± 7.8 years, 79.4% were males. A 5-year survival was 84.2%. The mean number of risk factors was 3.4 ± 1.0. Most of the patients were in New York Heart Associatiation (NYHA) II class (104 of them or 59.4%), 61 of them (34.9%) in NYHA III class and only 10 patients or 5.7% of them were in NYHA IV class. The mean End-Diastolic Diameter (EDD) was 55.3 ± 5.6 mm, mean End-Systolic Diameter (ESD) 38.7 ± 5.6 mm and mean ejection fraction (EF) 51.7 ± 9.6%. Left atrium dilatation (p < 0.001), as well as left ventricle dilatation (p < 0.001), low left ventricle ejection fraction (p < 0.001), multisegmental disorders of contractility (p < 0.001), and severe mitral regurgitation (p < 0.001) were in negative correlation with almost all dimensions of quality of life. ROC analysis showed that left ventricle EDD of 54.5 mm can be used as good cut-off value for prediction of optimal quality of life, with sensitivity of 57% and specificity of 70% (RR = 1.386), left ventricle ESD of 37.5 mm with sensitivity of 65% and specificity of 57% (RR = 0.855) and left ventricle EF of 50% with sensitivity of 61% and specificity of 70% (RR = 0.916). Conclusion. Echocardiographic parameters, that can easily be obtained preoperatively, have strong predictive value not only in postoperative survival, but also in determination of the quality of life of the patients five years after coronary artery bypass graft surgery.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Prevention, treatment and outcomes of left ventricular assist device driveline infections. A single center experience
    (2020)
    Putnik, Svetozar (16550571800)
    ;
    Terzić, Dusko (57195538891)
    ;
    Nestorović, Emilija (56090978800)
    ;
    Karan, Radmila (47161180600)
    ;
    Dobri, Milan (57215822773)
    ;
    Andrijasević, Vuk (57209304591)
    ;
    Zlatkovic, Mina (57215815589)
    ;
    Kostić, Nataša Kovačević (57215815186)
    ;
    Velinovic, Milos (6507311576)
    ;
    Ivanisevic, Dragan (57215819463)
    ;
    Ristić, Miljko (57214043577)
    INTRODUCTION: While the survival rates for patients with end-stage heart failure have dramatically improved with newer generations of left ventricular assist devices, LVAD-specific infections are important cause of morbidity, mortality, and hospital readmissions in these patients. METHODS: We performed a retrospective analysis of all driveline infections in patients who had undergone LVAD implantation at a single cardiosurgical center. Between June 2013 and March 2017, 51 patients underwent implantation of LVAD. Among these, 12 received Heart Ware LVAD,34 Heart Mate II LVAD, and 5 Heart Mate III LVAD. The end goal for LVAD therapy was destination therapy in three patients and bridge-to-transplantation in 48 patients. RESULTS: One month, six months, and one-year survival rates were 90%, 85%, and 81%, respectively. Five patients developed driveline infections. Median time from LVAD implantation to driveline infections was 126 days. One of these patients underwent heart transplantation. Two patients were treated with antibiotics and surgical driveline repositioning with extensive debridement of the wound. Two patients with a chronic infection were treated conservatively with regular wound cleaning. CONCLUSION: Driveline infections remain a serious therapeutic challenge. With the development of surgical techniques and new devices, it is possible to reduce morbidity and increase survival rate in patients with implanted LVAD. © 2020, Edizioni Luigi Pozzi. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Successful surgical treatment of terminal heart failure in an adolescent – Left ventricular assist device implantation and subsequent heart transplantation
    (2019)
    Putnik, Svetozar (16550571800)
    ;
    Terzić, Duško (57195538891)
    ;
    Nestorović, Emilija (56090978800)
    ;
    Marković, Dejan (26023333400)
    ;
    Ristić, Miljko (57214043577)
    Introduction Implantation of the new-generation left ventricular assist device (LVAD) is an efficient therapeutic option as a bridge to transplantation in adults, as well as in children and adolescents with small body surface. The aim of this work was to present a case of a successful surgical treatment of terminal heart failure in a male adolescent who had an LVAD implanted as a bridge to heart transplantation. Case outline The patient, a 17-year-old male, was admitted with the end-stage heart failure due to the dilated cardiomyopathy and implanted LVAD. Fourteen months after LVAD implantation, a successful “second stage” surgical procedure was performed – orthotopic heart transplantation preceded by the LVAD explantation. Conclusion Long-term mechanical circulatory support is an effective and safe method in treatment of the end-stage heart failure as a bridge to transplantation in the adolescent period. © 2019, Serbia Medical Society. All rights reserved.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback